 The Psychopharmacology Research Consortium
at the University of Nebraska Medical Center began its work
in 1984. Its purpose is to conduct research on
new treatments for the relief of mental disorders.This research involves conditions such as depression,
bipolar disorder, anxiety, attention deficit
hyperactivity disorder (ADHD) and Alzheimer's disease.
Studies include those funded by the National
Institutes of Health (NIH) as well as the pharmaceutical industry.
To learn more about the
Consortium, please click on the
buttons at left.
To learn more about clinical research, click
below:
Participating in Research
For more information or
to submit comments, click on our e-mail address: unmcprc@unmc.edu
|